HHCP
LMAT icon

Hilton Head Capital Partners’s LeMaitre Vascular LMAT Stock Holding History

Hilton Head Capital Partners’s Portfolio LMAT Stock Details LMAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$8.64K Hold
90
– – ﹤0.01% 599
2026
Q1 		$9.82K Hold
90
– – 0.01% 588
2025
Q4 		$7.3K Buy
+90
New +$7.75K ﹤0.01% 602

Other funds holding LMAT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CCA
Conestoga Capital Advisors Wayne, Pennsylvania $4.6B AUM 16.08% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
CCM
Copeland Capital Management Conshohocken, Pennsylvania $4.87B AUM 31.21% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Hilton Head Capital Partners's LMAT Position: Q2 2026 in Review

Hilton Head Capital Partners held its LeMaitre Vascular (LMAT) position steady in Q2 2026 at 90 shares worth $8.64K. The position accounts for ﹤0.01% of the portfolio, ranked #599.

Hilton Head Capital Partners first reported a position in LMAT in Q4 2025 and has held it in 3 quarters since. The position peaked at $9.82K in Q1 2026. 326 funds tracked by Wall St. Rank hold LMAT as of Q2 2026.

  • Hilton Head Capital Partners held 90 shares of LeMaitre Vascular worth $8.64K as of Q2 2026.
  • Hilton Head Capital Partners left its LeMaitre Vascular share count unchanged in Q2 2026.
  • LeMaitre Vascular made up ﹤0.01% of Hilton Head Capital Partners's portfolio in Q2 2026, its #599 holding.
  • Hilton Head Capital Partners first reported a position in LeMaitre Vascular in Q4 2025 and has held it in 3 quarters since.
  • Hilton Head Capital Partners's LeMaitre Vascular position peaked at $9.82K in Q1 2026.
  • 326 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q2 2026.

Based on Hilton Head Capital Partners's 13F filing for Q2 2026, filed 27 Jul 2026.